Pargluva structure
|
Common Name | Pargluva | ||
|---|---|---|---|---|
| CAS Number | 331741-94-7 | Molecular Weight | 516.54200 | |
| Density | 1.274g/cm3 | Boiling Point | 736.4ºC at 760 mmHg | |
| Molecular Formula | C29H28N2O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 399.2ºC | |
Use of PargluvaMuraglitazar is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia. Muraglitazar shows potent activity in vitro at human PPARα (EC50 = 320 nM) and PPARγ(EC50 = 110 nM)[1]. |
| Name | Muraglitazar |
|---|---|
| Synonym | More Synonyms |
| Description | Muraglitazar is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia. Muraglitazar shows potent activity in vitro at human PPARα (EC50 = 320 nM) and PPARγ(EC50 = 110 nM)[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.274g/cm3 |
|---|---|
| Boiling Point | 736.4ºC at 760 mmHg |
| Molecular Formula | C29H28N2O7 |
| Molecular Weight | 516.54200 |
| Flash Point | 399.2ºC |
| Exact Mass | 516.19000 |
| PSA | 120.12000 |
| LogP | 4.81940 |
| Index of Refraction | 1.601 |
| InChIKey | IRLWJILLXJGJTD-UHFFFAOYSA-N |
| SMILES | COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(-c4ccccc4)oc3C)cc2)cc1 |
| 2-[(4-methoxyphenoxy)carbonyl-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]amino]acetic acid |